INBX
Inhibrx Biosciences, Inc. · Healthcare
Chief Executive Officer Mark Lappe bought $999K of Inhibrx Biosciences, Inc.
Bought$998,784
$99.88Price
10,000Shares
+1%Stake
What INBX did for a copier
- $1,000 copied at Tue, Sep 29 open, $105.31
- $887
- S&P 500, same days
- −0.9%
18 of 30 trading days so far, to the Oct 23 close.
Mark Lappe's record
3 other buys with 3 months of prices since 2024: on average −17.0% against the S&P 500, and 0 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 25. Filed Mon, Sep 28, 5:47 PM ET, after the close. Returns use the Sep 29 open and the Oct 23 close. Not investment advice.